BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2542180)

  • 1. Shedding of virus-free MMTV gp52 by nonproducer mammary tumor cells: a source of tumor marker in the presence and absence of dexamethasone.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):102-10. PubMed ID: 2542180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative modification of dexamethasone-mediated MMTV gp52 release by progesterone pretreatment of tumor cells.
    Ritzi EM; Walthall EB
    Intervirology; 1989; 30(2):111-6. PubMed ID: 2542181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of mouse mammary tumor virus envelope glycoprotein (Gp52) by growth factors.
    Ritzi EM; Walthall EB
    Intervirology; 1988; 29(3):144-53. PubMed ID: 2846465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of mouse mammary tumor virus gp52 abundance by protein A assay: a comparison of viral antigen expression on C3H and GR mammary tumor cells.
    Callis AH; Ritzi EM
    Intervirology; 1981; 15(2):111-20. PubMed ID: 6271704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids stimulate the release of a viral tumor marker (MMTV gp52) while inhibiting tumor cell growth.
    Ritzi EM; Walthall EB
    J Steroid Biochem; 1989 Apr; 32(4):499-505. PubMed ID: 2542692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative flow cytometry of mouse mammary tumor virus envelope glycoprotein (gp52): alternative measures of hormone-mediated change in a viral cell surface antigen.
    Ritzi EM
    J Virol Methods; 1992 Oct; 40(1):11-30. PubMed ID: 1331158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of mouse mammary tumor virus cell surface antigens: estimation of antigen abundance by protein A assay.
    Callis AH; Ritzi EM
    J Virol; 1980 Sep; 35(3):876-87. PubMed ID: 6252344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids alter the level and distribution of mouse mammary tumor virus gp52 in vitro.
    Sunzeri FJ; Buehring GC
    Cancer Lett; 1993 Oct; 74(1-2):57-64. PubMed ID: 8287372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with spontaneous mammary tumors develop type-specific neutralizing and cytotoxic antibodies against the mouse mammary tumor virus envelope protein gp52.
    Schochetman G; Arthur LO; Long CW; Massey RJ
    J Virol; 1979 Oct; 32(1):131-9. PubMed ID: 94356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a C3Hf mammary tumor cell line expressing endogenous mouse mammary tumor virus: antigenic and genetic relationships of this virus with highly oncogenic mouse mammary tumor viruses.
    Arthur LO; Lovinger GG; Schochetman G
    J Virol; 1979 Dec; 32(3):852-9. PubMed ID: 92576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
    Sarkar NH; Racevskis J
    Virology; 1983 Apr; 126(1):279-300. PubMed ID: 6302986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of viral glycoprotein reflect enhanced effectiveness of combined drug treatments.
    Ritzi EM; Pyo S
    Life Sci; 1994; 54(13):887-99. PubMed ID: 8139377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoelectron microscopic localization of mammary tumor virus (MTV) antigens in normal and cancerous mammary glands of mice.
    Tsubura A; Shikata N; Hilgers J; Zotter S; Tanaka H; Morii S
    Microbiol Immunol; 1987; 31(7):665-74. PubMed ID: 2830473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and antigenic properties of mouse mammary tumor virus produced in a hormone-responsive fashion by C57Bl/10 mammary tumors of non-viral origin.
    Marchetti A; Svec J; Hlavay E; Veselovska Z; Castagna M; Squartini F
    Tumori; 1988 Jun; 74(3):261-7. PubMed ID: 2456634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative flow cytometry reveals a hierarchy of glucocorticoid effect on cell surface mouse mammary tumor virus gp52.
    Ritzi EM
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):33-42. PubMed ID: 8645615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice.
    Arthur LO; Fine DL
    J Virol; 1979 Apr; 30(1):148-56. PubMed ID: 90156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of a viral protein as a diagnostic signal for the presence of tumor : the murine mammary tumor model.
    Ritzi E; Martin DS; Stolfi RL; Spiegelman S
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4190-4. PubMed ID: 186789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
    Holder WD; Peer GW; Bolognesi DP; Wells SA
    Cancer Res; 1976 Sep; 36(9 pt.1):3217-24. PubMed ID: 184944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of a viral protein as a diagnostic signal for the presence of mammary tumor: the effect of tumor removal.
    Ritzi E; Martin DS; Stolfi RL; Spiegelman S
    J Exp Med; 1977 Apr; 145(4):999-1013. PubMed ID: 192830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.